Nucleic Acid Labeling Market - Industry Analysis, Market Size, Share, Trends, Growth and Forecast 2020 - 2025

Report Code: HCR 0479 Report Format: PDF + Excel (Delivery in 48 Hrs)
Nucleic Acid Labeling Market size is estimated to be $1.65 billion in 2019, growing at a CAGR of 8.5% during the forecast period 2020-2025.Rising geriatric population and the need of personalized medicines, increasing genomic and enzymology research and advancements in diagnostic tools for synthetic genome design and government initiatives for research and development in microbiology is a significant factor driving the nucleic acid labeling market during the forecast period 2020-2025.Nucleic acid may be modified with tags that enables detection and purification. The resulting nucleic acid probes can be used to identify or recover other interacting molecules. Common labels used to generated nucleic acid probe include radioactive phosphates, biotin, flurophores and enzymes.In addition the biconjugation method used for nucleic acid probe generation may be adapted for attaching molecules or surfaces to facilitate targeted delivery or immobilization. Nucleic acid labelling is a technique used to label nucleic acid for purification and visualization. In addition nucleic acid can be labelled at their 5’ end and 3’ end or throughout the molecule depending on a particular application to generate information on gene integrity and copy number, to diagnose specific sequences and chromosomal aberrations, to simultaneously measure the relative expressions of RNAs or to discover protein nucleic acid interactions. Common labels used to 

Report Coverage
The report: “Nucleic Acid Labeling Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Nucleic Acid Labelling Market.

By Type-Radioisotope Labeling and Non-Radioactive Labeling.
By Labeling Technique- Polymerase Chain Reaction, Nick Translation, Random Primer, In vitro Transcription and Others
By Application- DNA Sequencing, Microarrays, In situ hybridization, Blotting and Others
By End-User- Contract Research Organization, Academic & Research Institute and Others.
By Geography-North America, Europe, Asia-Pacific and RoW.

Key Takeaways
  • By Type Non-radioactive accounted for the largest market share in 2019 owing to its relative speed, sensitivity, safety and versatility.
  • Polymerase Chain Reaction accounted for the largest market share in 2019 owing to its sensivity that allows rapid amplification of a specific segment of DNA.
  • Increasing incidence of chronic diseases leading to diabetes and other cardiovascular diseases and the patients demand for personalized medicine is a major driving the Nucleic Acid Labeling Market during the forecast period 2020-2025.

By Type- Segment Analysis 
By Type Non-radioactive accounted for the largest market share in 2019 owing to its relative speed, sensitivity, safety and versatility. Furthermore, non-radioactive labels for RNA and DNA are widely used in molecular research labs thereby contributing to its market growth. Moreover, fluorescent and reactive labels help researchers investigate protein that interact with nucleotides at a single molecule level. Furthermore, non-radioactive detection methods eliminate the need to deal with licensing, waste disposal and safety concerns associated with the use of radioactive materials. The probes generated are more stable than are probes labeled with 32P.In addition, non-radioactive detection methods typically require shorter exposure times to detect the hybridization signal which is a significant factor driving the segment which in turn is boosting the nucleic acid labeling market during the forecast period 2020-2025.

By Labeling Technique- Segment Analysis
Polymerase Chain Reaction accounted for the largest market share in 2019 owing to its sensivity that allows rapid amplification of a specific segment of DNA. In addition it is a high sensitive technique with the potential to produce millions to billions of copies of a specific product for screening, cloning and analysis thereby increasing its demand. In addition to the rapidity with which this assay works, it is able to quantitatively measure how much of a particular sequence is present. Furthermore, technological advancements has led modified version of PCR which have allowed quantitative measurements for gene expression with techniques called real-time PCR thereby boosting the Nucleic Acid Labeling Market during the forecast period 2020-2025. The random primer segment is projected to be the fastest growing with a CAGR of 8.8% during the forecast period 2020-2025.

Geography- Segment Analysis
North America dominated the Nucleic Acid Labeling Market with a region share 40% in 2019 followed by Europe and APAC. Rising geriatric population along with the increasing health expenditure and government initiative, increasing health concerns coupled with the growing demand of advanced treatment and a better healthcare structure is a major factor propelling its market growth. Furthermore, the presence of major players and ease of availability of technology advanced instruments in that region is further driving its market growth. 

Drivers – Nucleic Acid Labeling Market
  • Growing Demand for Personalized Medicine
Increasing incidence of chronic diseases leading to diabetes and other cardiovascular diseases and the patients demand for personalized medicine is a major driving the Nucleic Acid Labeling Market during the forecast period 2020-2025.Futhermore, through this genome analysis scientist can personalize drugs to make them more effective, thereby improving treatment outcomes. Furthermore, this approach can be used to detect and diagnose diseases in a highly specific manner categorizing them by genetic variation rather than symptoms thereby attracting large number of patients towards it which in turn is boosting the nucleic acid labeling market.
  • Advancement in Tools for Synthetic Genome Design
With the remarkable development in sequencing technology, the genome of diverse species from bacteria to human have been completely sequenced. In addition the sequencing speed has greatly accelerated by the recent advent of next-generation sequencing (NGS) methods, which earlier followed the conventional capillary-based sequencing methods. NGS methods analyze various size and types of DNA libraries more accurately rapidly and cheaply in a throughout fashion thereby driving the market. NGS provide powerful tools not only to discover fundamental biological information such as whole genome-sequences, variations and DNA proteins interaction, but to also apply to diagnostic and clinical uses which is further contributing to its market growth.

Challenges – Nucleic Acid Labeling Market
  • Lack of Skilled Professional
Lack of Skilled Professional serves as a major setback for the growth of the  Nucleic Acid Labeling Market during the forecast period 2020-2025. Futher more owing to the lack of skilled professional an understanding of the interpretation of anti HCV-screening test results, when more specific testing should be performed and which test should be considered for this purpose.

Nucleic Acid Labeling Market Industry Outlook 
Product Launches, Merger & Acquistion, joint ventures and R&D activities are key strategies adopted by the players in Nucleic Acid Labeling Market. Nucleic Acid Labeling Market top 10 companies are Enzo Biochem Inc, GE Healthcare, Marker Gene Technologies Inc, Merck KGaA, Thermofisher Scientific Inc, Vector Lavoratories Inc, Agilent Technologies, Promega Corporation, New England Biolabs and General Electric Company.

Developments:
  • April 2020: ThermoFisher Scientific Inc launched AcroMetric Coronavirus 2019 RNA Control to monitor and validate covid-19 molecular diagnostic test.
1. Nucleic Acid Labeling Market Overview
    1.1 Definitions and Scope
2. Nucleic Acid Labeling Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Type
    2.3 Key trends by Labeling Technique
    2.4 Key trends by Application
    2.5 Key trends by End-User
    2.6 Key trends by Geography
3. Nucleic Acid Labeling Market –Comparative Analysis
    3.1 Product Benchmarking - Key companies
    3.2 Financials Analysis - Key Companies
    3.3 Market Share Analysis- Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Nucleic Acid Labeling Market- Startup companies Scenario Premium (Premium) 
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Nucleic Acid Labeling Market – Industry Market Entry Scenario Premium (Premium) 
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Nucleic Acid Labeling Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Nucleic Acid Labeling Market -Strategic analysis
    7.1 Value chain analysis 
    7.2 Opportunities analysis
    7.3 Market life cycle
8. Nucleic Acid Labeling Market – By Type(Market Size –$Million/$Billion)
    8.1 Radioisotope Labeling
    8.2 Non-Radioactive Labeling
        8.2.1 Fluorescent
        8.2.2 Biotin
        8.2.3 Streptavidin
        8.2.4 Flurophores
        8.2.5 Others
9. Nucleic Acid Labeling Market – By Labeling Technique(Market Size –$Million/$Billion)
    9.1 Polymerase Chain Reaction
    9.2 Nick Translation
    9.3 Random Primer
    9.4 In Vitro Transcription 
    9.5 Reverse Transcription
    9.6 End Labeling
    9.7 Others
10. Nucleic Acid Labeling Market – By Application(Market Size –$Million/$Billion)
    10.1 DNA Sequencing
    10.2 In Situ Hybridization
    10.3 Blotting
    10.4 Microarrays
    10.5 Others
11. Nucleic Acid Labeling Market – By End-User(Market Size –$Million/$Billion)
    11.1 Contract Research Organization
    11.2 Academic & Research Institute
    11.3 Others
12. Nucleic Acid Labeling Market - By Geography (Market Size -$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 Japan
        12.3.3 South Korea
        12.3.4 India
        12.3.5 Australia & New Zealand
        12.3.6 Rest of APAC
    12.4 Rest of the World
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Nucleic Acid Labeling Market - Entropy
14. Nucleic Acid Labeling Market – Industry/Segment Competition Landscape   (Premium) 
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Country- Key companies
        14.1.4 Best Practices for Companies
15. Nucleic Acid Labeling Market – Key Company List by Country Premium (Premium)
16. Nucleic Acid Labeling Market Company Analysis
    16.1 Company Revenue, Products, M&A, Developments
    16.2 Enzo Biochem Inc
    16.3 GE Healthcare
    16.4 Marker Gene Technologies Inc
    16.5 Merck KGaA
    16.6 Thermofisher Scientific Inc
    16.7 Agilent Technologies
    16.8 Promega Corporation
    16.9 New England Labs
    16.10 General Electric Company
*Financials for private companies would be provided on a best efforts basis”.